METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING DISEASES

摘要

Disclosed herein are new oral pharmaceutical compositions of SAMDC inhibitors, polyamine analogs, and polyamine biosynthesis inhibitors, and their application for the treatment of conditions including demyelinating diseases, autoimmune disorders affecting the nervous system, and other neurodegenerative conditions.

主权项

1. A method of treatment or prevention of demyelination in a subject in need thereof, comprising the administration of a therapeutically effective amount of MGBG.